Document is current
Any future updates will be listed below
-
Authors
Ross, Maya https://orcid.org/0000-0001-6525-7032
Sade, Kareen
Obolensky, Alexey
Averbukh, Edward
Desrosiers, Melissa https://orcid.org/0000-0003-2776-9664
Rosov, Alexander
Dvir, Hay https://orcid.org/0000-0002-5024-5626
Gootwine, Elisha
Banin, Eyal
Dalkara, Deniz https://orcid.org/0000-0003-4112-9321
Ofri, Ron https://orcid.org/0000-0002-3825-3113
-
Funding
Funding for this research was provided by:
Ministry of Health, State of Israel (3-0000-15068)
Ministry of Health, State of Israel (3-0000-15068)
Ministry of Health, State of Israel (3-0000-15068)
Ministry of Health, State of Israel (3-0000-15068)
Ministry of Health, State of Israel (3-0000-15068)
Ministry of Health, State of Israel (3-0000-15068)
Ministry of Health, State of Israel (3-0000-15068)
Ministry of Health, State of Israel (3-0000-15068)
Ministry of Health, State of Israel (3-0000-15068)
Ministry of Health, State of Israel (3-0000-15068)
Israel Science Foundation (1257/15)
Israel Science Foundation (1257/15)
Israel Science Foundation (1257/15)
Israel Science Foundation (1257/15)
Israel Science Foundation (1257/15)
Israel Science Foundation (1257/15)
Israel Science Foundation (1257/15)
Israel Science Foundation (1257/15)
Israel Science Foundation (1257/15)
Israel Science Foundation (1257/15)
- License Information
-
More Information
Article History
Received: 12 June 2024
Revised: 10 October 2024
Accepted: 11 October 2024
First Online: 29 October 2024
Competing interests
: M. Ross, none; K. Sade, none; A. Obolensky none; E. Averbukh, none; M. Desrosiers, None A. Rosov, none; H. Dvir, none; E. Gootwine, none; E. Banin, none; D. Dalkara reports grants from Foundation Fighting Blindness, USA and European Research Council, during the conduct of the study; DD is a co-inventor on patent #9193956 (Adeno-associated virus virions with variant capsid and methods of use thereof), with royalties paid to Adverum Biotechnologies and on pending patent applications on noninvasive methods to target cone photoreceptors (EP17306429.6 and EP17306430.4) licensed to Gamut Tx now Sparing- Vision. DD also has personal financial interests in Tenpoint Tx. and SparingVision, outside the scope of the submitted work; R. Ofri, none.
: Experimental protocols were approved by the Agricultural Research Organization, Volcani Center, Animal Experimentation Ethics Committee, Permit 643/16
